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Implications for Nursing Care
Discovering the Pathophysiology of Reperfusion Injury After Myocardial Ischemia
Rachel Fetrow, RN MSN
Introduction and Background
Myocardial infarction remains a leading cause of death in the United States. Lack of 
blood flow to the heart causes an imbalance between oxygen supply and demand 
resulting in damage to the myocardium. Timely restoration of blood flow is the first line 
treatment to prevent tissue injury. However, the process of reperfusion can itself 
induce cardiomyocyte death, known as myocardial reperfusion injury (Hausenloy & 
Yellon, 2013)  
Sudden reintroduction of molecular oxygen to energy starved tissue results in a 
unique type of injury response that is not manifested during the period of hypoxic 
stress. The discovery of this reoxygenation-dependent injury response, which is now 
commonly called “reperfusion injury”, opened a new field of research that, despite 
many therapeutic strategies, is just being translated to bedside care. (Granger & 
Kvietys, 2015). 
I chose this topic because the pathophysiology of reperfusion injury can lead to 
extensive damage and poor clinical outcomes. According to Frank et al., 2012, 
myocardial ischemia reperfusion injury accounts for up to 50% of the final size of a 
myocardial infarct. Myocardial damage contributes to significant comorbidities and 
patient quality of life is dramatically influenced by the amount of preserved myocardial 
function after ischemia. The following information presented will outline the 
pathophysiology of myocardial reperfusion injury and the clinical implications for 
nursing care. 
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Figure: Schematic of main proponents of myocardia acute ischemic
reperfusion injury (Hausenloy & Yellon, 2013)
Significance of Reperfusion Injury
⟡ Reperfusion Arrythmia The most 
common reperfusion arrhythmia is 
accelerated idioventricular (AIVR), 
however ventricular premature 
contractions, sustained or non-sustained 
episodes of V-Tach, A-fib and V-fib are 
also observed (Tatli et al, 2013). 
⟡ Myocardial Stunning Reversible 
post-ischemic contractile dysfunction  
occurs on reperfusion of acute ischemic 
myocardium, resulting from the 
detrimental effects of oxidative stress and 
intracellular calcium overload on the 
myocardial contractile apparatus 
(Hausenloy & Yellon, 2013).
⟡ Microvascular obstruction Occurs 
because of the vasculature’s inability to 
reperfuse the previously ischemic area. 
(Hausenloy & Yellon, 2013). Contributing 
factors include capillary damage with 
impaired vasodilatation, external capillary 
compression by endothelial cell and 
cardiomyocyte swelling, embolization 
from the atherosclerotic plaque, micro-
thrombi, the release of soluble vasomotor 
and thrombogenic substances, and 
neutrophil plugging. The presence of MVO 
is associated with a larger MI size, a lower 
LV ejection fraction, adverse ventricular 
remodeling, and worse clinical outcomes 
(Hausenloy & Yellon, 2013).
⟡ Intramyocardial hemorrhage In 
severe cases of MVO extravasation of 
blood into the interstitium can produce 
intramyocardial hemorrhage within the 
area of infarction. It is a severe form of 
microvascular obstruction with a 
tendency to expand for several hours 
after percutaneous coronary intervention. 
According to Hamirani, Wong, Kramer 
and Salerno, 2015, the cause includes 
vascular endothelial damage and 
accumulation of red blood cells in the 
myocardial extracellular space. Vessels 
are injured by the initial ischemia but are 
reperfusable at the time of reflow. The 
result is a subsequent increase in 
intersitial pressure, again compromising 
tissue perfusion (Simonis, Strasser and 
Ebner 2012). Multiple factors contribute 
to the presence and severity of 
intramyocardial hemorrhage, including 
the amount of collateral flow, ischemic 
preconditioning, extent of necrosis, distal 
coronary microembolization, and patient 
risk factors.
Although the process of 
myocardial reperfusion has been 
optimized following a STEMI, the 
process of restoring coronary blood 
flow can induce cardiomyocyte death, 
thereby mitigating the full benefits of 
reperfusion in terms of MI size 
reduction. Therapeutic intervention 
administered solely at the time of 
myocardial reperfusion can reduce MI 
size by up to half, limiting incidence of 
LV remodeling and heart failure. 
Several molecular targets have been 
discussed in the influence of potential 
successful therapeutic management, 
however, standard clinical practice 
protocols are continuing to develop 
for optimal reperfusion injury 
prevention. 
⟡ Cardiomyocyte death 
Reperfusion-induced death of 
cardiomyocytes that were viable at the 
end of the index ischemic event is 
defined as lethal myocardial 
reperfusion injury. The existence of 
lethal myocardial reperfusion injury 
has been inferred in both 
experimental MI models and in 
patients with STEMI by the 
observation that therapeutic 
interventions applied solely at the 
onset of myocardial reperfusion 
reduced infarct size significantly 
(Hausenloy & Yellon, 2013). One study 
demonstrated a 36% reduction in MI 
size in reperfused-STEMI patients 
randomized to receive ischaemic post-
conditioning. (Frolich et al 2013). 
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⟡ Inflammation Neutrophils block 
capillaries preventing reperfusion of the 
tissue, leading to tissue necrosis and an 
exacerbated immune response. Secretion 
of proinflammatory cytokines and 
chemokines recruite and activate 
neutrophils (Schofield, Woodruff, Halai, 
Chia-Lun Wu, & Cooper, 2013) This, as 
well as membrane expression of cell-
adhesion molecules, induces leukocyte 
infiltration within the myocardial tissue. 
These leukocytes have the potential to 
release large amount of reactive oxygen 
species, contributing to further tissue 
damage. (Braunersreuther & Jaquet, 
2012)
⟡ Oxidative Stress. Influx of oxygen 
introduced during reperfusion. Unpaired 
electrons formed during the normal 
metabolism of oxygen accumulate due to 
an excessive reintroduction of oxygen. 
ROS overwhelm the endogenous 
elimination mechanism by antioxidants. 
This oxidative stress results in 
impairment of normal function of 
circulating molecules.  (Braunersreuther
& Jaquet, 2012).  
Underlying Pathophysiology 
What is actually happening?
⟡ Intracellular pH changes 
Interruption of oxygen supply leads to 
arrest of mitochondrial oxidative 
phosphorylation and loss of the major 
source of ATP generation for metabolic 
energy” (Braunersreuther & Jaquet, 
2012). Anaerobic glycolysis takes over 
and produces hydrogen ions and 
lactate, leading to intracellular acidosis.  
At reperfusion, physiological pH is 
rapidly restored by the washout of 
lactate and the activation of the Na+-H+ 
exchange. This pH shift contributes to 
the MPTP opening and ultimately 
cardiomyocyte death (Hausenloy & 
Yellon, 2013). 
⟡ Calcium overload. The calcium 
overload is likely related to the effects 
of oxidative stress on the sarcolemmal
Ca2+-pump ATPase, and Na+-K+ 
ATPase, leading to decreased efflux and 
increased influx of calcium. It also 
depresses the sarcoplasmic reticulum 
Ca2+-pump ATPase. These Ca2+ 
transport system dysfunctions 
ultimately lead to intracellular calcium 
overload. (Braunersreuther & Jaquet, 
2012). 
⟡ Mitochondria transition pore opening Oxidative stress, calcium overload and 
intracellular change in pH all interact with each other to allow mitochondrial 
permeability transition pore (MPTP) opening. The MPTP is a nonselective channel of the 
inner mitochondrial membrane. Upon reperfusion, restoration of oxygen rapidly 
improves mitochondrial membrane potential, stimulating additional calcium influx, 
uncoupling of oxidative phosphorylation and the opening of the MPTP. (Shluter, 2016, p. 
230). According to Simonis et al 2012 this phenomenon does not occur in ischemia but is 
a key determinant in the first few minutes of myocardial reperfusion. This ultimately 
contributes to uncontrolled activation of the contractile machinery leading to 
hypercontracture and cardiomyocyte death. (Hausenloy & Yellon, 2013). 
STEMI patients with a complete occlusion in a large artery with little coronary 
collateralization are most likely to benefit from a therapeutic intervention (Frolich
et al. 2013). 
⟡ Ischemic post conditioning therapy.  Four-60 second inflations/deflations of 
the angioplasty balloon with low pressure upstream from the stent following 
deployment has been shown to reduce MI size (Frolich et al 2013). The 
protocol for this therapy should be followed within 1 minute of stent 
deployment.
⟡ Hyperoxemia and Hypothermia Hyperbaric oxygen reduces MI size by 
decreasing tissue edema, reducing formation of lipid peroxide radicals, 
altering NO synthase expression and inhibiting leucocyte adherence and 
plugging in the microcirculation. Lowering myocardial temperature during 
ischemia to 32–33°C can limit MI size in experimental studies by reducing 
metabolic demand, inflammatory response, platelet aggregation, and 
increasing myocardial efficiency. (Frolich et al, 2013).
⟡ Remote Ischemic Conditioning. Applying three-5 min cycles of brief non-lethal 
ischemia and reperfusion using a blood pressure cuff applied to the upper 
arm. Applying this RIC protocol to STEMI patients immediately prior to 
reperfusion has demonstrated increased myocardial salvage (Simonis et al. 
2012). The actual mechanisms, although unclear, have been attributed to a 
neuro-hormonal pathway conveying the cardioprotective signal from the limb 
to the heart.
⟡ Pharmacologic intervention Is debated due to several therapies that have 
proven therapeutic in controlled laboratory settings but unsuccessful in 
clinical practice. The following offers insight into pharmacotherapies that 
have shown some positive outcome.
•  Cyclosporin-A is an immunosuppressant drug that prevents the 
formation of the MPTP by binding with cyclo D (Sivaraman & Yellon, 2013).
• Atrial natriuretic peptide. Administering atrial natriuretic peptide (ANP) 
at reperfusion reduced MI size through the activation of pro-survival 
signaling pathways. Carperitide reduced MI size and preserved LV ejection 
fraction in reperfused-STEMI patients. (Frolich et al, 2013).
•Exenatide, a glucagon-like peptide-1 (GLP-1) agonist has demonstrated
reduced MI size when administered at the time of reperfusion and has been
successfully translated in the clinical setting. (Frolich et al, 2013). 
Signs and Symptoms
⟡ Ventricular Function
An increasing number of patients are developing heart failure. 
Understanding the implications of reperfusion injury to preserve LV 
systolic function and prevent the onset of heart failure may facilitate 
the discovery of new effective therapies for reducing MI size and 
preventing heart failure in patients presenting with reperfused
STEMI (Bullock, Yellon and Hausenloy 2016). For this reason, 
therapeutic interventions for reducing reperfusion injury have been 
a viable target for cardioprotection in clinical practice
Illustration: Players involved in ischemia 
reperfusion injury (Ibanez et al, 2015)
